Chamness GC - Search Results

1

Translational research in the San Antonio breast cancer SPORE.

Osborne CK, Chamness GC. Osborne CK, et al. Among authors: chamness gc. Breast Cancer Res Treat. 1994;32(1):1-4. Breast Cancer Res Treat. 1994. PMID: 7819578 No abstract available.

2

Alteration of EGF-receptor binding in human breast cancer cells by antineoplastic agents.

Hanauske AR, Osborne CK, Chamness GC, Clark GM, Forseth BJ, Buchok JB, Arteaga CL, Von Hoff DD. Hanauske AR, et al. Among authors: chamness gc. Eur J Cancer Clin Oncol. 1987 May;23(5):545-51. doi: 10.1016/0277-5379(87)90318-x. Eur J Cancer Clin Oncol. 1987. PMID: 3498632

3

Tumor biologic factors and breast cancer prognosis among white, Hispanic, and black women in the United States.

Elledge RM, Clark GM, Chamness GC, Osborne CK. Elledge RM, et al. Among authors: chamness gc. J Natl Cancer Inst. 1994 May 4;86(9):705-12. doi: 10.1093/jnci/86.9.705. J Natl Cancer Inst. 1994. PMID: 7908990

4

Cathepsin D by western blotting and immunohistochemistry: failure to confirm correlations with prognosis in node-negative breast cancer.

Ravdin PM, Tandon AK, Allred DC, Clark GM, Fuqua SA, Hilsenbeck SH, Chamness GC, Osborne CK. Ravdin PM, et al. Among authors: chamness gc. J Clin Oncol. 1994 Mar;12(3):467-74. doi: 10.1200/JCO.1994.12.3.467. J Clin Oncol. 1994. PMID: 8120545

5

Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancer.

Allred DC, Clark GM, Elledge R, Fuqua SA, Brown RW, Chamness GC, Osborne CK, McGuire WL. Allred DC, et al. Among authors: chamness gc. J Natl Cancer Inst. 1993 Feb 3;85(3):200-6. doi: 10.1093/jnci/85.3.200. J Natl Cancer Inst. 1993. PMID: 8423624

6

Mitosin (a new proliferation marker) correlates with clinical outcome in node-negative breast cancer.

Clark GM, Allred DC, Hilsenbeck SG, Chamness GC, Osborne CK, Jones D, Lee WH. Clark GM, et al. Among authors: chamness gc. Cancer Res. 1997 Dec 15;57(24):5505-8. Cancer Res. 1997. PMID: 9407959

7

The small heat shock protein HSP27 is not an independent prognostic marker in axillary lymph node-negative breast cancer patients.

Oesterreich S, Hilsenbeck SG, Ciocca DR, Allred DC, Clark GM, Chamness GC, Osborne CK, Fuqua SA. Oesterreich S, et al. Among authors: chamness gc. Clin Cancer Res. 1996 Jul;2(7):1199-206. Clin Cancer Res. 1996. PMID: 9816288

8

Time-dependence of hazard ratios for prognostic factors in primary breast cancer.

Hilsenbeck SG, Ravdin PM, de Moor CA, Chamness GC, Osborne CK, Clark GM. Hilsenbeck SG, et al. Among authors: chamness gc. Breast Cancer Res Treat. 1998;52(1-3):227-37. doi: 10.1023/a:1006133418245. Breast Cancer Res Treat. 1998. PMID: 10066085

9

Clinical response to neoadjuvant docetaxel predicts improved outcome in patients with large locally advanced breast cancers.

Tham YL, Gomez LF, Mohsin S, Gutierrez MC, Weiss H, Hilsenbeck SG, Elledge RM, Chamness GC, Osborne CK, Allred DC, Chang JC. Tham YL, et al. Among authors: chamness gc. Breast Cancer Res Treat. 2005 Dec;94(3):279-84. doi: 10.1007/s10549-005-9020-z. Breast Cancer Res Treat. 2005. PMID: 16261403 Clinical Trial.

10

Gene expression patterns in formalin-fixed, paraffin-embedded core biopsies predict docetaxel chemosensitivity in breast cancer patients.

Chang JC, Makris A, Gutierrez MC, Hilsenbeck SG, Hackett JR, Jeong J, Liu ML, Baker J, Clark-Langone K, Baehner FL, Sexton K, Mohsin S, Gray T, Alvarez L, Chamness GC, Osborne CK, Shak S. Chang JC, et al. Among authors: chamness gc. Breast Cancer Res Treat. 2008 Mar;108(2):233-40. doi: 10.1007/s10549-007-9590-z. Epub 2007 Apr 28. Breast Cancer Res Treat. 2008. PMID: 17468949 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

106 results

Search Page